At the XXII International Conference on HIV/AIDS in Amsterdam, we managed to talk with Natalia Sidorenko, a specialist having a long practical experience in the field of TB services, as well as an expert of the regional group of the PARTNERSHIP program implemented in Eastern ...

Call for Membership (2018 – 2020) to the Developing Country NGO Delegation to the Board of The Global Fund to Fight AIDS, Tuberculosis and Malaria

Last December, Ministry of Social Affairs and National Institute for Health Development from Estonia, WHO European Region, UNAIDS and the Global Fund organised a two day meeting on challenges and opportunities in national HIV and TB programmes management.

EECA is one of two regions where transition planning is most advanced

On 21 March 2018, the Global Fund Board approved six country grants worth $102.9 million. This was the seventh batch of approvals from the 2017–2019 allocations, and brings the cumulative amount awarded to date to just under $9 billion.

Petition signed by more than 30,000 people from 120 countries presented to head of WHO and Ministers of Health.

The world spent $726 million on tuberculosis (TB) research in 2016, marking the first time annual spending has exceeded $700 million since TAG began tracking funding in 2005.

Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis

Global progress to End TB not fast enough to reach global TB and HIV targets

The countries involved account for 55% of all missed cases of TB and multidrug-resistant TB

Join Treatment Action Group (TAG) and the Global Coalition of TB Activists (GCTA) for a webinar on how civil society and community groups can initiate a dialogue with their national governments in advance of the Ministerial Conference in Moscow. Wednesday, October 25 8:30 a.m. - 10:00 a.m. ET Panelists ...

Former Soviet countries in the Eastern European and Central Asian (EECA) region are fighting the prevailing perception that their outdated hospital-based tuberculosis (TB) programs are failing to provide patient-centered care. Since 2005, Georgia has emerged as the regional leader in decentralizing TB services and implementing ...

The Medicines Patent Pool (MPP) announced that it has signed a Memorandum of Understanding (MoU) with Otsuka to accelerate the development and manufacturing of, and access to, paediatric formulations containing delamanid for multidrug-resistant tuberculosis (MDR-TB). Delamanid 50mg tablet was recently added to the World Health Organization’s Essential ...

The report published today focuses on the status of current, emerging and potential technologies in TB diagnosis. Many countries still rely on tools such as sputum-smear microscopy but new diagnostics are slowly changing the TB diagnostics landscape. Tuberculosis (TB) continues to be a major public health ...

Released in advance of the 9th IAS Conference on HIV Science convening next week in Paris, our 2017 report continues to demonstrate the significant yields of drugs and biologics research and the advancement of breakthrough technologies that aim to detect, prevent, treat or cure HIV, tuberculosis ...

Individuals and organizations interested in signing on to a civil society version of the Moscow Declaration that could serve as a blueprint for commitments and action toward ending the global impacts of tuberculosis over the next decade and a half have one more day to ...

As the government prepares to take on more financial responsibility, the country still faces challenges because of ongoing conflict Ukraine has submitted a TB/HIV funding request worth $119.5 million that the country expects will help broaden services, especially among key populations. The proposal includes a further ...

Indian scientists from the University of Delhi have identified molecules that could effectively inhibit TB virus and have published all the results of the study in Scientific Reports journal. The molecules are targeting a gene, important for  the bacterium’s survival. Possibly they may find a new ...